The number of disorders that benefit from hematopoietic stem cell transplantation (HSCT)
has increased, causing the overall number of HSCT to increase accordingly. Disorders …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an evidence based-
cellular immunotherapy for hematological malignancies. Immune reactions not only promote …

Pretransplant respiratory virus infections (RVIs) have been shown to negatively affect
hematopoietic cell transplantation (HCT) outcomes. The impact of and need for delay of HCT …

Hematopoietic cell transplantation (HCT) uses cytotoxic chemotherapy and/or radiation
followed by intravenous infusion of stem cells to cure malignancies, bone marrow failure and …

Rationale: Oral microbiota associate with diseases of the mouth and serve as a source of
lung microbiota. However, the role of oral microbiota in lung disease is unknown. Objectives …

OBJECTIVES: To determine the association between preintubation respiratory support and
outcomes in patients with acute respiratory failure and to determine the impact of …

Limited understanding of the immunopathogenesis of human herpesvirus 6B (HHV-6B) has
prevented its acceptance as a pulmonary pathogen after hematopoietic cell transplant …

Impaired baseline lung function is associated with mortality after pediatric allogeneic
hematopoietic cell transplantation (HCT), yet limited knowledge of the molecular pathways …

Although the lungs were once considered a sterile environment, advances in sequencing
technology have revealed dynamic, low-biomass communities in the respiratory tract, even …

Pulmonary infectious complications post HSCT remain a devastating complication for
children and their families. Despite improvements in standard and novel diagnostic …